Cool cap could keep hair on during chemo

NCT ID NCT06215469

Ongoing Symptom relief Sponsor: University of California, San Francisco Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a portable scalp cooling system called Amma to see if it can prevent hair loss in women receiving chemotherapy for early-stage breast cancer. Forty women with stage I-III breast cancer will use the cooling cap during their chemo sessions. The goal is to see if most women keep at least half their hair, with fewer side effects.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Amma Portable Scalp Cooling System (a cooling cap device)
What this could lead to: If it works, this device could help women keep most of their hair during chemotherapy, reducing emotional distress.
What could go wrong: This is a small, post-market study with only 40 participants, so results may not apply to everyone. The device may cause discomfort or fail to prevent hair loss for some.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALOPECIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

alopecia breast cancer breast neoplasm chemotherapy-induced alopecia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ALOPECIA BREAST CANCER CHEMOTHERAPY-INDUCED ALOPECIA EARLY-STAGE BREAST CANCER HAIR LOSS

Contacts and locations

Locations

University of California, San Francisco

San Francisco, California, 94143, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.